Ancient herb mix may reverse precancerous stomach damage
NCT ID NCT07391800
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a traditional Chinese herbal formula (Compound Granules of Hedyotis diffusa) in 20 adults with chronic atrophic gastritis, a condition that can lead to stomach cancer. Participants take the herbal granules for 12 months and are followed for another 12 months. The goal is to see if the treatment can improve stomach lining damage and reduce cancer risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Compound Granules of Hedyotis diffusa (a mix of three herbs: Hedyotis diffusa, Smilax china L., and Solanum lyratum Thunb.)
What this could lead to
If it works, this could point toward a non-drug treatment to reverse stomach lining damage and lower gastric cancer risk.
What could go wrong
This is a very small early study with only 20 people and no comparison group, so results may not be reliable or apply to others. The herbal mix is not yet proven or widely accepted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ATROPHIC GASTRITIS WITH HYPERPLASIA (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
Shanghai, 200000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••